Latest News

First trial to investigate magic mushrooms as a treatment for depression delayed by UK and EU regulations

The world?s first clinical trial to explore the use of the hallucinogenic ingredient in magic mushrooms to treat depression is being delayed due to the UK and EU rules on the use of illegal drugs in research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Memory decline among menopausal women could be next research frontier for hypnotic relaxation therapy

  • Immersed in violence: How 3-D gaming affects video game players

  • Three-minute assessment successfully identifies delirium in hospitalized elders

  • Largest study of Hispanics/Latinos finds depression, anxiety rates vary widely among groups

  • Stress-related inflammation may increase risk for depression

  • No relationship between moderate adolescent cannabis use, exam results or IQ, large study shows

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • For prescription drug addiction treatment, buprenorphine maintenance trumps detoxification

  • Key factor in transition from moderate to problem drinking

  • A rich vocabulary can protect against cognitive impairment

  •